Rep. Lisa C. McClain Buys Option Care Health, Inc. (NASDAQ:OPCH) Shares

Representative Lisa C. McClain (R-Michigan) recently bought shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $1,001 and $15,000 in Option Care Health stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded up $1.07 during midday trading on Tuesday, reaching $30.99. 362,984 shares of the company were exchanged, compared to its average volume of 1,922,297. The stock has a market cap of $4.92 billion, a P/E ratio of 24.76, a PEG ratio of 1.74 and a beta of 0.88. Option Care Health, Inc. has a 1 year low of $22.29 and a 1 year high of $35.53. The stock has a fifty day simple moving average of $27.74 and a 200 day simple moving average of $29.41. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. USA Financial Formulas purchased a new position in Option Care Health in the 2nd quarter valued at approximately $26,000. Cornerstone Planning Group LLC increased its position in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after buying an additional 1,067 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after buying an additional 836 shares during the last quarter. Advisory Services Network LLC purchased a new stake in shares of Option Care Health in the 3rd quarter worth about $35,000. Finally, McIlrath & Eck LLC purchased a new position in Option Care Health during the 2nd quarter valued at about $37,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have commented on OPCH. Citizens Jmp cut their price objective on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research report on Friday, October 31st. Morgan Stanley began coverage on shares of Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective for the company. Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Option Care Health in a report on Wednesday, November 19th. Finally, Wall Street Zen downgraded Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Nine research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was bought at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the acquisition, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. The trade was a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.64% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.